| Literature DB >> 21553905 |
Erika Balog1, David Perahia, Jeremy C Smith, Franci Merzel.
Abstract
Neutron scattering experiments have demonstrated that binding of the cancer drug methotrexate softens the low-frequency vibrations of its target protein, dihydrofolate reductase (DHFR). Here, this softening is fully reproduced using atomic detail normal-mode analysis. Decomposition of the vibrational density of states demonstrates that the largest contributions arise from structural elements of DHFR critical to stability and function. Mode-projection analysis reveals an increase of the breathing-like character of the affected vibrational modes consistent with the experimentally observed increased adiabatic compressibility of the protein on complexation.Entities:
Mesh:
Substances:
Year: 2011 PMID: 21553905 DOI: 10.1021/jp108493g
Source DB: PubMed Journal: J Phys Chem B ISSN: 1520-5207 Impact factor: 2.991